BRIEF-Array Biopharma provides NEMO update By: Reuters: Company News March 19, 2017 at 17:06 PM EDT * Array Biopharma Inc - Has withdrawn from U.S. FDA division of oncology products 2 its new drug application (NDA) for binimetinib monotherapy Read More >> Related Stocks: Array Technologies Inc